We also observed co-expression of PKCα and PKCδ and downstream target BCL2 in our SU2C/PFC NEPC NRP1 + population (Fig. S3), confirming the existence of this phenotype in human advanced PCa samples. The gene discussed is BCL2; the disease is posterior cortical atrophy.